340B Patient Advisory Committee

AIDS Drug Assistance Programs

• Is the 340B Drug Pricing Program the Next ‘Too Big to Fail’? (March 2025)

  • ¿Será el programa 340B el próximo "demasiado grande para quebrar"?

• Resolution Calling for Industry 340B Carveout for State AIDS Drug Assistance Programs (December 2023)

  • Resolución por la que se solicita una excepción a la norma industrial 340B para los programas estatales de ayuda a los medicamentos contra el SIDA

Executive Compensation & Charity Care

• Summary: 340B Program Eligibility, Executive Compensation, and Charity Care (October 2023)

  • Resumen: Elegibilidad para el programa 340B, Remuneración de Ejecutivos y Atención de Beneficencia

• Blog: 340B Covered Entities’ Revenue Witnessed Huge Executive Compensation Increases, Alarming Charity Care Decreases (November 2023)

  • Bloguero: Los Ingresos de Las Entidades Cubiertas Por El 340B Experimentaron Enormes Aumentos de La Remuneración de Los Ejecutivos y Alarmantes Descensos de la Asistencia Caritativa

• The 340B Drug Pricing Program and its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities (July 2024)

  • El programa de precios de medicamentos 340B y sus posibles repercusiones en los ingresos anuales, la retribución de los directivos y la prestación de cuidados caritativos en las entidades cubiertas elegibles

• 340B Drug Pricing Program: Charity Care Declines & Medical Debt Explodes (November 2024)

• 340B Drug Pricing Program: Charity Care Declines (November 2024)

• 340B Drug Pricing Program: Medical Debt Explodes (November 2024)

• The 340B Drug Pricing Program and its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities – Supplemental Report (February 2025)

  • El programa de precios de medicamentos 340B y sus posibles repercusiones en los ingresos anuales, la retribución de los directivos y la prestación de cuidados caritativos en las entidades cubiertas elegibles

• Patient Medical Debt: Findings from Quantitative Surveying of Patients in the United States (April 2025)

  • Deuda Médica del Paciente: Hallazgos de Encuestas Cuantitativas a Pacientes en los Estados Unidos

• The 340B Drug Pricing Program and its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities – Supplemental Report 2 (December 2025)

Rebate Model

• Amicus Curiae Brief filed in Case No. 1:24-cV-03337 (DLF): BRISTOL MYERS SQUIBB, INC. V. DOROTHY FINK, in her official capacity, and U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (February 2025)

• Amicus Curiae Brief filed in Civil Case No. 1:24-cv-3188: JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. V. XAVIER BECERRA, in his official capacity, and U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (February 2025)

Safety Net & Charity Care

• 340B: A Critical Safety Net to Help Patients Access Their Medications (July 2024)

  • 340B: Una Red de Seguridad Crítica Para Ayudar a Los pAcientes Acceder a Sus Medicamentos

BACK TO TOP